DIFFERENTIAL (HA-, K- AND N-) RAS P21 EXPRESSION IN BENIGN AND MALIGNANT HUMAN THYROID-TUMORS - AN IMMUNOHISTOCHEMICAL STUDY

Citation
Y. Mizukami et al., DIFFERENTIAL (HA-, K- AND N-) RAS P21 EXPRESSION IN BENIGN AND MALIGNANT HUMAN THYROID-TUMORS - AN IMMUNOHISTOCHEMICAL STUDY, Anticancer research, 15(3), 1995, pp. 755-759
Citations number
26
Categorie Soggetti
Oncology
Journal title
ISSN journal
02507005
Volume
15
Issue
3
Year of publication
1995
Pages
755 - 759
Database
ISI
SICI code
0250-7005(1995)15:3<755:D(KANR>2.0.ZU;2-X
Abstract
An immunohistochemical study of 24 thyroid carcinomas, 10 thyroid aden omas and 10 normal thyroids was performed using monoclonal antibodies directed against each of the three members of ras p21s; Ha-, K- and N- ras p21. Normal thyroids showed a negative staining for all of the thr ee ms p21s. The expressional levels of the three ras p21s were various in each benign and malignant thyroid tumor; but a higher expression o f Ha- and N-ras p21 and a lower or negative expression of K-ras p21 wa s a common finding in thyroid tumors of all histologic categories. The re were no correlations between the expressional levels of ms p21s and the histologic subtypes, tumor size or lymph node status in the thyro id carcinomas.